Group items tagged

The card industry in Egypt is forecasted to grow at a CAGR of 6.48% from 16.5 million cards to 21.3 million cards between 2013 and 2017. Egypt's card industry witnessed strong growth between 2008 and 2012 recording an impressive CAGR of 14.07% even as it grew from 9.1 million cards to 15.4 million cards. The industry is forecasted to grow at a CAGR of 6.48% between 2013 and 2017, from 16.5 million cards to 21.3 million cards.

"Analytical Tool - Breast Cancer" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in breast cancer R&D and business development.

"Analytical Tool: Lymphoma" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in lymphoma R&D and business development.

"Analytical Tool - Colorectal Cancer" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in colorectal cancer R&D and business development.

"Analytical Tool - Pancreatic Cancer" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in pancreatic cancer R&D and business development. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current treatment strategies and their progress. This tool provides you with an immense amount of information structured and analyzed to assist you in your work.

"Analytical Tool - Prostate Cancer" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in prostate cancer R&D and business development.

Indian companies are taking center stage in Complex Generics at US and EU markets. In Bio-similars, Indian companies will have perhaps the largest basket aimed at Emerging Countries in 2014-16 and later for Developed countries.

"Analytical Tool - Cancer Therapeutic Antibodies" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in antibody drug development for the treatment of cancer.